- Home
- RCKT vs LADR Comparison
RCKT vs LADR Comparison
Compare RCKT & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- LADR
- Stock Information
- Founded
- RCKT 1999
- LADR 2008
- Country
- RCKT United States
- LADR United States
- Employees
- RCKT N/A
- LADR N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- LADR Real Estate Investment Trusts
- Sector
- RCKT Health Care
- LADR Real Estate
- Exchange
- RCKT Nasdaq
- LADR Nasdaq
- Market Cap
- RCKT 1.3B
- LADR 1.5B
- IPO Year
- RCKT N/A
- LADR 2014
- Fundamental
- Price
- RCKT $11.74
- LADR $11.29
- Analyst Decision
- RCKT Strong Buy
- LADR Buy
- Analyst Count
- RCKT 11
- LADR 6
- Target Price
- RCKT $50.27
- LADR $13.33
- AVG Volume (30 Days)
- RCKT 1.3M
- LADR 607.1K
- Earning Date
- RCKT 11-07-2024
- LADR 02-06-2025
- Dividend Yield
- RCKT N/A
- LADR 7.88%
- EPS Growth
- RCKT N/A
- LADR N/A
- EPS
- RCKT N/A
- LADR 0.76
- Revenue
- RCKT N/A
- LADR $257,005,000.00
- Revenue This Year
- RCKT N/A
- LADR N/A
- Revenue Next Year
- RCKT $234,928.88
- LADR N/A
- P/E Ratio
- RCKT N/A
- LADR $15.36
- Revenue Growth
- RCKT N/A
- LADR N/A
- 52 Week Low
- RCKT $11.58
- LADR $10.10
- 52 Week High
- RCKT $32.53
- LADR $12.48
- Technical
- Relative Strength Index (RSI)
- RCKT 27.69
- LADR 32.54
- Support Level
- RCKT $11.58
- LADR $11.74
- Resistance Level
- RCKT $15.00
- LADR $11.97
- Average True Range (ATR)
- RCKT 0.82
- LADR 0.21
- MACD
- RCKT -0.09
- LADR -0.06
- Stochastic Oscillator
- RCKT 4.65
- LADR 6.36
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.